Approval · Notice of Compliance 3972 · 1997
SYNFLEX/SYNFLEX DS: Notice of Compliance 3972
Issued March 26, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3972
- Date
- March 26, 1997
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Analgesic, anti-inflammatory agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SYNFLEX/SYNFLEX DS | 00675369 | Cancelled Post Market |
| SYNFLEX/SYNFLEX DS | 01900897 | Cancelled Post Market |
Medicinal ingredients
- NAPROXEN SODIUM 275 MG per TAB
- NAPROXEN SODIUM 550 MG per TAB